United States
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2,531.62
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
2 |
USD 1,476.72
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
3 |
USD 302.56
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
4 |
USD 291.46
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
5 |
USD 237.88
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
6 |
USD 207.73
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
7 |
USD 176.92
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
8 |
USD 174.23
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
9 |
USD 144.69
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
10 |
USD 138.28
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
11 |
USD 59.46
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
12 |
USD 54.52
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
13 |
USD 49.94
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
14 |
USD 41.15
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
15 |
USD 36.43
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
16 |
USD 35.18
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
17 |
USD 33.44
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
18 |
USD 30.04
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
19 |
USD 28.92
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
20 |
USD 28.92
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
21 |
USD 23.22
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
22 |
USD 22.76
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
23 |
USD 20.51
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
24 |
USD 12.65
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
25 |
USD 12.60
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
26 |
USD 12.58
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
27 |
USD 10.37
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
28 |
USD 8.50
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
29 |
USD 8.21
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
30 |
USD 5.82
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
31 |
USD 5.76
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
32 |
USD 4.75
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
33 |
USD 2.04
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest Revenue Per Share is McKesson Corporation (NYSE: MCK) at USD 2,531.62.
The Drugstores & Retail Pharmacies company in United States with the lowest Revenue Per Share is GoodRx Holdings, Inc. (NasdaqGS: GDRX) at USD 2.04.
The top 10 Drugstores & Retail Pharmacies companies in United States by Revenue Per Share are McKesson Corporation, Cencora, Ingles Markets, Incorporated, CVS Health Corporation, Ulta Beauty, Inc., The Kroger Co., Weis Markets, Inc., Walgreens Boots Alliance, Inc., Lennox International Inc. and Albertsons Companies, Inc..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Revenue Per Share are GoodRx Holdings, Inc., National Retail Properties, Inc., Innoviva, Inc., biote Corp., ShotSpotter, Inc., Biofrontera Inc., Xponential Fitness, Inc., Viatris Inc., Aytu BioPharma, Inc. and PetMed Express, Inc..